Therma Bright Inc (TSX-V:THRM, OTC:TBRIF, FRA:JNX) CEO Rob Fia tells Proactive the Toronto, Ontario-based group has recently upgraded to the OTCQB platform in the US, while it makes progress with its AcuVid™ COVID-19 Rapid Antigen Saliva Test.
The diagnostic and medical device technology company says upgrading to the QB gives the company more access to US investors. Most recently, it completed and submitted additional research and documentation requested by the FDA, to gain Emergency Use Authorization on its saliva test.